Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02606708 · ClinicalTrials.gov registry record · NA
Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 314
- Enrollment target
NCT02606708 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 314 participants.
The verdict
NCT02606708, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 314 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine the feasibility and tolerability of a regimen of accelerated (hypofractionated) Intensity Modulated Radiation Therapy (AIMRT) to the whole breast as part of breast preservation. In addition, the investigators want to prospectively collect blood specimens to: assess TGF-β polymorphisms to identify potential carriers at higher risk for post-treatment fibrosis; generate a blood specimen repository for future studies of other relevant polymorphisms. The study investigators also want to prospectively follow each treated woman yearly to assess long-term radiation sequelae of the current regimen by using the LENT/SOMA scores.
Interventions
- RADIATION Accelerated intensity modulated radiation therapy (AIMRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 314 participants |
| Start Date | 2005-02-20 |
| Est. Completion | 2017-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02606708
The ClinicalTrials.gov registry entry for NCT02606708 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Accelerated intensity modulated radiation therapy (AIMRT) is the first listed.
NCT02606708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02606708 about?
NCT02606708 is a clinical study titled "Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy". The primary purpose of this study is to determine the feasibility and tolerability of a regimen of accelerated (hypofractionated) Intensity Modulated Radiation Therapy (AIMRT) to the whole breast as part of breast preservation. In addition, the investigators want to prospectively collect blood speci...
What is the current status of trial NCT02606708?
This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2005-02-20. Estimated completion is 2017-06-02.
What interventions are being tested in trial NCT02606708?
The interventions under investigation include: Accelerated intensity modulated radiation therapy (AIMRT) (RADIATION).
Who is sponsoring clinical trial NCT02606708?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.